ArticleJCO clinical cancer informatics2025

Development of a Dynamic Counterfactual Risk Stratification Strategy for Newly Diagnosed Patients With AML Treated With Venetoclax and Azacitidine.

Nazmul Islam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.